Angelica LaVito, CNBC.com’s Posts

Johnson & Johnson outlined plans to grow its pharmaceutical business on Wednesday.

J&J CEO Alex Gorsky told CNBC that the company needs to focus on new innovations.

Walmart plans to increase the minimum age to buy tobacco products to 21 starting July 1, joining a growing list of retailers under pressure from federal regulators to curb sales to minors and boosting their age restrictions as a result.

U.S. health officials confirmed another 78 cases of measles last week, urging people to vaccinate as they battle the worst year for the disease in 25 years.

Walgreens is increasing the age to buy tobacco at its drugstores to 21 later this year as the retailer faces possible sanctions from the Food and Drug Administration for allegedly selling to minors.

Johnson & Johnson’s mounting legal costs ate into its first-quarter profits, which dropped 14% as it fights thousands of lawsuits over its talc baby powder and shelled out almost $400 million to settle 25,000 cases over its blockbuster blood thinner Xarelto.

Outgoing FDA chief Scott Gottlieb releases a much-anticipated draft policy restricting e-cigarette sales to curb an “epidemic” of teen use.

Juul created a new enterprise markets team to strike deals with health plans, providers, self-insured employers, as well as public sector.